Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting (vol 5, pg 353, 2016)

被引：0
|
作者：
Deck, Daniel H. [1 ]
Jordan, Jennifer M. [1 ]
Holland, Thomas L. [2 ]
Fan, Weihong [1 ]
Wikler, Matthew A. [1 ]
Sulham, Katherine A. [1 ]
Corey, G. Ralph [2 ]
机构：
[1] Med Co, Parsippany, NJ 07054 USA
[2] Duke Univ Hosp, Durham, NC USA
来源：
INFECTIOUS DISEASES AND THERAPY | 2016年 / 5卷 / 03期
关键词：
D O I：
10.1007/s40121-016-0127-9
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：363 / 365
页数：3
相关论文
共 25 条
  • [1] Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
    Deck D.H.
    Jordan J.M.
    Holland T.L.
    Fan W.
    Wikler M.A.
    Sulham K.A.
    Ralph Corey G.
    Infectious Diseases and Therapy, 2016, 5 (3) : 353 - 361
  • [2] Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
    Daniel H. Deck
    Jennifer M. Jordan
    Thomas L. Holland
    Weihong Fan
    Matthew A. Wikler
    Katherine A. Sulham
    G. Ralph Corey
    Infectious Diseases and Therapy, 2016, 5 (3) : 363 - 365
  • [3] Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
    Corey, G. Ralph
    Kabler, Heidi
    Mehra, Purvi
    Gupta, Sandeep
    Overcash, J. Scott
    Porwal, Ashwin
    Giordano, Philip
    Lucasti, Christopher
    Perez, Antonio
    Good, Samantha
    Jiang, Hai
    Moeck, Greg
    O'Riordan, William
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (23): : 2180 - 2190
  • [4] Oritavancin, a single-dose, complete regimen, for the treatment of acute bacterial skin and skin structure infections
    Wu, Gary
    Truong, James
    Lee, Spencer
    Elnadoury, Ola
    Kuan, William
    Abraham, Teena
    Wu, Anh
    Liu, Mei
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (04) : 409 - 416
  • [5] Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections
    Rappo, Urania
    Gonzalez, Pedro L.
    Puttagunta, Sailaja
    Akinapelli, Karthik
    Keyloun, Katelyn
    Gillard, Patrick
    Liu, Yan
    Dunne, Michael W.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 17 : 60 - 65
  • [6] Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
    Garnock-Jones, Karly P.
    DRUGS, 2017, 77 (01) : 75 - 83
  • [7] Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
    Karly P. Garnock-Jones
    Drugs, 2017, 77 : 75 - 83
  • [8] Single-Dose Oritavancin Versus 7-10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study
    Corey, G. Ralph
    Good, Samantha
    Jiang, Hai
    Moeck, Greg
    Wikler, Matthew
    Green, Sinikka
    Manos, Paul
    Keech, Richard
    Singh, Rajesh
    Heller, Barry
    Bubnova, Natalia
    O'Riordan, William
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (02) : 254 - 262
  • [9] SEVERITY AND COSTS OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS BY TREATMENT SETTING: AN APPLICATION OF THE ERON CLASSIFICATION TO A REAL-WORLD DATABASE
    Sulham, K.
    LaPensee, K.
    Fan, W.
    Lodise, T. P.
    VALUE IN HEALTH, 2014, 17 (03) : A282 - A282
  • [10] Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials
    Lodise, Thomas P.
    Redell, Mark
    Armstrong, Shannon O.
    Sulham, Katherine A.
    Corey, G. Ralph
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
123